Skip to content

Comparison of Oliceridine and Alfentanil in Fiberoptic Bronchoscopy under General Anesthesia with Laryngeal Mask Airway

Comparison of Oliceridine and Alfentanil in Fiberoptic Bronchoscopy under General Anesthesia with Laryngeal Mask Airway

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500098235
Enrollment
Unknown
Registered
2025-03-05
Start date
2025-03-10
Completion date
Unknown
Last updated
2025-03-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dyspnea

Interventions

Control Group:Alfentanil

Sponsors

Anshan Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. The patient is over 18 years old; 2, American Society of Anesthesiologists (ASA) grade I - II I; 3. Voluntarily sign informed consent.

Exclusion criteria

Exclusion criteria: 1. The patient's history is not detailed; 2. Systolic blood pressure >180mm Hg or diastolic blood pressure >110mm Hg, heart rate <50 beats/min; 3. The patient had predicted difficult airway; 4, have a history of serious heart, brain, lung, liver, kidney and metabolic diseases; 5. History of mental illness, drug abuse and dependence, drug allergy;

Design outcomes

Primary

MeasureTime frame
Blood Pressure;Heart Rate;Oxygen Saturation;Respiratory Rate;

Secondary

MeasureTime frame
Incidence of Cough Reflex;Incidence of Nausea and Vomiting;Incidence of Respiratory Depression;Incidence of Delayed Recovery;Pain Intensity;

Countries

China

Contacts

Public ContactLihong Du

Anshan Central Hospital

ghdlh@126.com+86 138 9800 0012

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026